Chloasma fading essence microcapsule and preparation method thereof

A technology of microcapsules and essences, applied in cosmetic preparations, cosmetics, pharmaceutical formulations, etc., to maintain skin stability, prevent pigmentation, and lighten melasma.

Inactive Publication Date: 2018-09-21
SUZHOU COSMETIC MATERIALS
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem solved by the present invention: In order to overcome the defects of the prior art, obtain a kind of essence that can dilute chloasma, and prevent the skin from causing adverse stimul

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] A microcapsule of chloasma lightening essence. The microcapsule is a transparent spherical soft capsule with a core-shell structure, wherein the capsule wall is a sericin shell membrane, and the capsule core is a chloasma lightening essence. The mass ratio is 1:1, and the diameter of the microcapsules is 2 mm; by weight, the chloasma lightening essence includes: 7 parts of squalane, 3 parts of vitamin E, 2 parts of vitamin C, and 1 part of human lysozyme , 2 parts of aloe vera extract, 8 parts of pomegranate seed extract, 2 parts of grape seed extract, 3 parts of tea polyphenols, 2 parts of allantoin, 3 parts of hyaluronic acid.

[0019] The preparation method of described lightening chloasma essence microcapsule, described method comprises the following steps:

[0020] (1) Prepare a sericin solution containing 230mmol / L metal ions, adjust the pH to 6, and place it in a thermostat at 30°C for reaction after continuous stirring;

[0021] (2) Centrifuge the solution afte...

Embodiment 2

[0027] A microcapsule of chloasma lightening essence. The microcapsule is a transparent spherical soft capsule with a core-shell structure, wherein the capsule wall is a sericin shell membrane, and the capsule core is a chloasma lightening essence. The mass ratio is 2:1, and the diameter of the microcapsules is 3 mm; by weight, the chloasma lightening essence includes: 11 parts of squalane, 6 parts of vitamin E, 5 parts of vitamin C, and 2 parts of human lysozyme , 6 parts of aloe vera extract, 11 parts of pomegranate seed extract, 5 parts of grape seed extract, 7 parts of tea polyphenols, 8 parts of allantoin, and 7 parts of hyaluronic acid.

[0028] The preparation method of described lightening chloasma essence microcapsule, described method comprises the following steps:

[0029] (1) Prepare a sericin solution containing 250mmol / L metal ions, adjust the pH to 7, and place it in a constant temperature box at 34°C for reaction after continuous stirring;

[0030] (2) Centrif...

Embodiment 3

[0036] A microcapsule of chloasma lightening essence. The microcapsule is a transparent spherical soft capsule with a core-shell structure, wherein the capsule wall is a sericin shell membrane, and the capsule core is a chloasma lightening essence. The mass ratio is 3:1, and the diameter of the microcapsules is 6 mm; by weight, the chloasma lightening essence includes: 19 parts of squalane, 9 parts of vitamin E, 8 parts of vitamin C, and 3 parts of human lysozyme , 8 parts of aloe vera extract, 16 parts of pomegranate seed extract, 8 parts of grape seed extract, 11 parts of tea polyphenols, 11 parts of allantoin, 9 parts of hyaluronic acid.

[0037] The preparation method of described lightening chloasma essence microcapsule, described method comprises the following steps:

[0038] (1) Prepare a sericin solution containing 260mmol / L metal ions, adjust the pH to 8, and place it in a constant temperature box at 37°C for reaction after continuous stirring;

[0039] (2) Centrifug...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a chloasma fading essence microcapsule and a preparation method thereof. The microcapsule refers to transparent spherical soft capsule having core-shell structure, wherein thewall of the capsule refers to sericin shell membrane, the core of the capsule refers to chloasma fading essence, the mass ratio of the wall to the core of the capsule is (1-3) :1, and the diameter ofthe microcapsule ranges from 2mm to 6mm. The chloasma fading essence microcapsule comprises, by weight, 7-19 parts of squalane, 3-9 parts of Vitamin E, 2-8 parts of Vitamin C, 1-3 parts of human lysozyme, 2-8 parts of aloe extract, 8-16 parts of pomegranate seed extract, 2-8 parts of grape seed extract, 3-11 parts of tea polyphenol, 2-11 parts of allantoin and 3-9 parts of hyaluronic acid. The chloasma fading essence microcapsule can effectively fade chloasma, prevent hyperpigmentation, repair stratum corneum of damaged skin and maintain skin stability, and has no pessimal stimulation to skin.

Description

technical field [0001] The invention belongs to the technical field of cosmetics, and relates to a basic skin care product, in particular to an essence microcapsule for lightening chloasma and a preparation method thereof. Background technique [0002] Facial chloasma is a brown or light brown pigmentation abnormality and calming skin disease that occurs on the face. It usually grows in the eye sockets, cheeks, sides of the nose, etc. The boundaries of the spots are clear and the current status is different in size. , starting as dots and small flakes, and later expanding into patches, shaped like a butterfly, so it is called "butterfly spots". The etiology has not been clarified, but it is related to some medical diseases, such as chronic liver disease, dysmenorrhea, irregular menstruation, chronic metritis adnexitis, uterine fibroids, tuberculosis, and chronic alcoholism. Drugs, such as oral contraceptives and sun exposure, are more closely related to endocrine disorders ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K8/9794A61K8/9789A61K8/11A61K8/73A61K8/49A61K8/64A61K8/66A61K8/67A61K8/31A61Q19/02A61Q19/00
CPCA61K8/11A61K8/31A61K8/4946A61K8/498A61K8/64A61K8/66A61K8/676A61K8/678A61K8/735A61K8/9789A61K8/9794A61Q19/00A61Q19/02
Inventor 金仲恩全春兰张帆喻国贞欧阳智琨陈晋纳
Owner SUZHOU COSMETIC MATERIALS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap